Can't do better on my phone.
Not huge amount of time to scour as I'm busy
Appears on first glance that patent lodgement for cardioprotection properties as a blanket with all anticancer indications was rejected as its not a reasonable assumption that because it can protect from anthracyclines that it will also impart cardioprotection to other agents.
I'm *really* rushing here as I'm real busy and doing two other jobs, so hopefully someone else can look at it better.
I didn't see a suggestion that cardioprotection for anthracylines was rejected (paragraphs I saw re: same, seemed exciting on a glance)
I'll wait for someone with more time hopefully and/or official announcements
General Comments / Chat, page-7697
-
- There are more pages in this discussion • 4,251 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.060(3.79%) |
Mkt cap ! $259.9M | |||
| Open | High | Low | Value | Volume |
| $1.54 | $1.56 | $1.53 | $130.2K | 84.73K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4993 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 10451 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |